CellaVision AB (CEVI):企業の財務・戦略的SWOT分析

◆英語タイトル:CellaVision AB (CEVI) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1583
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

CellaVision AB (CEVI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

CellaVision AB (CellaVision) is a medical technology company that provides digital solutions for medical microscopy in hematology. The company helps hematology laboratories improve and transform the analysis of blood and other body fluids. It has expertise in digital image analysis, automated microscopy and artificial intelligence. The company’s product portfolio includes analyzers for automated medical microscopy analysis, software and applications for the healthcare and veterinary market. Through its global partners, CellaVision distributes its products in Europe, the Middle East and Africa (EMEA), Asia Pacific and North America. CellaVision is headquartered in Lund, Sweden.

CellaVision AB Key Recent Developments

Feb 05,2020 CellaVision: Nomination Committee proposes re-election of Chairman and members to the Board of Directors
Feb 05,2020 CellaVision: Year-end bulletin, Jan-Dec 2019
Oct 23,2019 CellaVision: Continued growth and acquisition of RAL Diagnostics
Jul 16,2019 CellaVision strongest quarter ever with continued growth

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
CellaVision AB – Key Facts
CellaVision AB – Key Employees
CellaVision AB – Key Employee Biographies
CellaVision AB – Major Products and Services
CellaVision AB – History
CellaVision AB – Company Statement
CellaVision AB – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
CellaVision AB – Business Description
Product Category: Instruments
Performance
Product Category: Other
Performance
Product Category: Reagents
Performance
Geographical Segment: APAC
Performance
Geographical Segment: EMEA
Performance
Geographical Segment: The Americas
Performance
CellaVision AB – Corporate Strategy
CellaVision AB – SWOT Analysis
SWOT Analysis – Overview
CellaVision AB – Strengths
CellaVision AB – Weaknesses
CellaVision AB – Opportunities
CellaVision AB – Threats
CellaVision AB – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
CellaVision AB, Medical Equipment, Deals By Year, 2014 to YTD 2020
CellaVision AB, Medical Equipment, Deals By Type, 2014 to YTD 2020
CellaVision AB, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 05, 2020: CellaVision: Nomination Committee proposes re-election of Chairman and members to the Board of Directors
Feb 05, 2020: CellaVision: Year-end bulletin, Jan-Dec 2019
Oct 23, 2019: CellaVision: Continued growth and acquisition of RAL Diagnostics
Jul 16, 2019: CellaVision strongest quarter ever with continued growth
May 07, 2019: CellaVision: Interim report January-March 2019
Feb 07, 2019: CellaVision- year-end bulletin, Jan-Dec 2018
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
CellaVision AB, Key Facts
CellaVision AB, Key Employees
CellaVision AB, Key Employee Biographies
CellaVision AB, Major Products and Services
CellaVision AB, History
CellaVision AB, Other Locations
CellaVision AB, Subsidiaries
CellaVision AB, Key Competitors
CellaVision AB, Ratios based on current share price
CellaVision AB, Annual Ratios
CellaVision AB, Annual Ratios (Cont...1)
CellaVision AB, Annual Ratios (Cont...2)
CellaVision AB, Interim Ratios
CellaVision AB, Medical Equipment, Deals By Year, 2014 to YTD 2020
CellaVision AB, Medical Equipment, Deals By Type, 2014 to YTD 2020
CellaVision AB, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
CellaVision AB, Performance Chart (2015 - 2019)
CellaVision AB, Ratio Charts
CellaVision AB, Medical Equipment, Deals By Year, 2014 to YTD 2020
CellaVision AB, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[CellaVision AB (CEVI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Leukocare AG-製薬・医療分野:企業M&A・提携分析
    Summary Leukocare AG (Leukocare) is a clinical stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company offers services such as development of individual SPS formulations meeting i …
  • PT Supreme Cable Manufacturing & Commerce Tbk (SCCO):企業の財務・戦略的SWOT分析
    PT Supreme Cable Manufacturing & Commerce Tbk (SCCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Zynerba Pharmaceuticals Inc (ZYNE):企業の財務・戦略的SWOT分析
    Summary Zynerba Pharmaceuticals Inc (Zynerba Pharmaceuticals), formerly AllTranz Inc, is a developer of next-generation synthetic cannabinoid therapeutics. The company provides pipeline product candidates such as ZYN002 and ZYN001. Its ZYN002 is a synthetic CBD, a non-psychoactive cannabinoid, formu …
  • UGL Ltd:企業の戦略的SWOT分析
    UGL Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Seres Therapeutics Inc (MCRB):製薬・医療:M&Aディール及び事業提携情報
    Summary Seres Therapeutics Inc (Seres), is a microbiome therapeutics platform company that develops a novel class of biological drugs. The company creates a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. The company’ …
  • Trimedyne Inc (TMED):企業の戦略的SWOT分析
    Trimedyne Inc (TMED) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • First Derivatives plc (FDP):企業の財務・戦略的SWOT分析
    First Derivatives plc (FDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Fluidic Analytics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Fluidic Analytics Ltd (Fluidic Analytics) is a biotechnology company that offers diagnostic tools to sequence and characterize proteins in laboratory, medical and consumer applications. The company offers Flow Mk-1 and Flow Mk-2 products. Flow Mk-1 is a lab instrument, which comprises dispos …
  • Emerson Electric Co (EMR)-エネルギー分野:企業M&A・提携分析
    Summary Emerson Electric Co. (Emerson) is a provider of infrastructure technologies and life cycle services for information and communication technology systems. The company offers hardware and software solutions for power, thermal and infrastructure management under the brands of Kop-Flex, jaure, a …
  • Molecular Partners AG (MOLN):企業の財務・戦略的SWOT分析
    Summary Molecular Partners AG (Molecular Partners) is a clinical stage biopharmaceutical company that develops biological drugs. The company offers advanced small protein therapies such as abicipar, a designed ankyrin repeat protein based anti-angiogenic drug developed for diabetic macular edema and …
  • Artes Biotechnology GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Artes Biotechnology GmbH (ARTES) is a developer of recombinant production cell lines and processes that is based on the microbial expression platforms. The company offers biosimilars, enzymes and proteins and vaccines. It offers technology transfer and implementation support, protein analyti …
  • Elavon, Inc.:企業の戦略・SWOT・財務情報
    Elavon, Inc. - Strategy, SWOT and Corporate Finance Report Summary Elavon, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • South Jersey Industries Inc (SJI):石油・ガス:M&Aディール及び事業提携情報
    Summary South Jersey Industries Inc (SJI) is an energy services holding company that sources and supplies natural gas and electricity. It develops, owns, and operates on-site energy production facilities. The company provides wholesale commodity marketing and fuel management services; and also offer …
  • Barclays Bank of Kenya Ltd:企業の戦略・SWOT・財務分析
    Barclays Bank of Kenya Ltd - Strategy, SWOT and Corporate Finance Report Summary Barclays Bank of Kenya Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • DexTech Medical AB:製薬・医療:M&Aディール及び事業提携情報
    Summary DexTech Medical AB (DexTech) is a research company that conducts research in the areas of urological oncology, mainly within prostate cancer. The company develops product candidates based on a modified carbon hydrate molecule combined with active substances such as generics. Its technology p …
  • Tufts University-製薬・医療分野:企業M&A・提携分析
    Summary Tufts University (Tufts) is an educational and research university that offers undergraduate and postgraduate courses in various fields. The university offer courses in anthropology, applied mathematics, architectural engineering, physics, archaeology, Asian American studies, biochemistry, b …
  • Dino Polska S.A (DNP):企業の財務・戦略的SWOT分析
    Dino Polska S.A (DNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Banque Degroof Petercam Private Banking:企業の戦略・SWOT・財務情報
    Banque Degroof Petercam Private Banking - Strategy, SWOT and Corporate Finance Report Summary Banque Degroof Petercam Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • SNC-Lavalin Group Inc (SNC):電力:M&Aディール及び事業提携情報
    Summary SNC-Lavalin Group Inc. (SNC-Lavalin) is a provider of engineering and construction services. The company offers a range of engineering, procurement, construction, project management services to various industries, which include oil and gas, mining and metallurgy, infrastructure and power. In …
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196)-製薬・医療分野:企業M&A・提携分析
    Summary Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆